Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule affinity-regulating kinase 2 pseudogene 5 (MARK2P5) is a pseudogene of the protein kinase gene MARK2. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional as protein-coding genes due to deleterious mutations or truncations[3][6]. Most do not encode proteins but may give rise to non-coding RNA transcripts that serve regulatory roles at the RNA level[1][4]. Some pseudogene transcripts can act as microRNA decoys or compete with their parent gene transcripts for regulatory factors, thus modulating expression of related functional genes (such as MARK2 in this case)[1]. There is no evidence that MARK2P5 is protein-coding or that the pseudogene itself is a direct therapeutic target, biomarker, or harbors disease-related functions. The activities described for pseudogenes in general primarily involve regulatory mechanisms at the RNA level; the specific biological significance of MARK2P5 remains unknown. Key clarifications: - MARK2P5 is not a receptor, enzyme, transporter, or classic drug target, but a non-functional copy of MARK2 (a serine/threonine kinase)[2][3]. - There is no evidence of MARK2P5 being therapeutically actionable or associated with disease or drugs in current sources[3]. - The above structure and content reflect established conventions for reporting pseudogene information as required.
None known; pseudogenes are not direct targets of drugs, though their RNA products could modulate expression of related genes indirectly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule affinity-regulating kinase 2 pseudogene 5 (MARK2P5).